BioInsights publishes four peer-reviewed, open-access journals: Cell & Gene Therapy Insights, Nucleic Acid Insights, Vaccine Insights and Bioconjugate Insights. Each covers its field from discovery to commercial manufacture. They have 64000 registered readers, from the bench to the C-suite. For solution providers, that is a direct route to market.
You can reach them at any point in the year, with your existing content or content we create with you. Our editors are subject specialists who work daily with leading experts and emerging research, and every one of our designers holds a science degree. They work with you from concept to campaign, or rework what you already have. Your content reaches readers from an independent publisher they trust, and we report on how it performs.
Our audience is made up of the teams that buy from suppliers like you. They work in process development, analytics, quality, supply and regulation, making cell and gene therapies, vaccines, nucleic acids and conjugates at scale. They register with BioInsights for practical answers to the problems your products and services solve.
We put your content in front of them on the topics they already come to us for. Our editors are subject specialists who work with leading experts every day, and they shape your material into the formats these readers use.
Matched to the problem you solve: recent coverage includes analytical methods to ICH Q14, AAV polishing, residual host cell DNA, closed fill-finish QC and the move to GMP bioreactors. You reach the readers working on the problem your product addresses.
Targeted by topic, not just job title: every reader registers against at least one specific topic. You choose the problem area, and we reach the people working on it.
The credibility of an expert-led platform: the journals are shaped by advisory boards that include directors of academic GMP facilities, CMC assessors from national regulators, and heads of process development and CMC at therapy developers. Your content carries the BioInsights name.
Attention you can see: a median of 254 registrations per webinar and 42 minutes average viewing time. Registrations and performance are reported to you.
Area of work
A content piece on your own website is a sales document, however good the science. The same data, published independently alongside peer-reviewed research, is evidence. BioInsights gives your solutions the standing that makes scientists take it seriously and puts your experts in front of a new field before anyone knows their names
| Objectives | Launching new data | Brand awareness | Lead generation | Product launch | People profiling | Demonstrating expertise | Networking | Sharing case studies | Generating traffic |
|---|---|---|---|---|---|---|---|---|---|
| Content Marketing | |||||||||
| 60-minute webinar | Applies | Applies | Applies | Applies | Applies | Applies | Not selected | Applies | Not selected |
| Live 30 webinar | Applies | Applies | Applies | Applies | Not selected | Not selected | Not selected | Applies | Not selected |
| Panel webinar | Applies | Applies | Applies | Applies | Applies | Applies | Not selected | Applies | Not selected |
| Webinar based article | Applies | Applies | Applies | Applies | Applies | Applies | Not selected | Applies | Not selected |
| Article (gated) | Applies | Applies | Applies | Applies | Not selected | Applies | Not selected | Applies | Not selected |
| Article (ungated) | Applies | Applies | Not selected | Applies | Applies | Applies | Not selected | Applies | Not selected |
| Interview | Not selected | Applies | Not selected | Applies | Applies | Applies | Not selected | Not selected | Not selected |
| Tech Showcase | Applies | Applies | Applies | Applies | Not selected | Applies | Not selected | Applies | Not selected |
| Infographic | Applies | Applies | Applies | Not selected | Not selected | Applies | Not selected | Not selected | Not selected |
| E-book | Not selected | Applies | Applies | Not selected | Not selected | Applies | Not selected | Not selected | Not selected |
| Podcast | Not selected | Applies | Not selected | Applies | Applies | Applies | Not selected | Not selected | Not selected |
| Special Interest Group | Not selected | Applies | Applies | Not selected | Applies | Not selected | Applies | Applies | Applies |
| Direct Promotion | |||||||||
| E-blast | Applies | Applies | Not selected | Applies | Not selected | Not selected | Not selected | Not selected | Applies |
| Newsletter sponsorship | Not selected | Applies | Not selected | Not selected | Not selected | Not selected | Not selected | Not selected | Applies |
| Nurture email | Not selected | Applies | Applies | Applies | Not selected | Not selected | Not selected | Not selected | Applies |
| Focus area sponsorship | Not selected | Applies | Not selected | Not selected | Not selected | Not selected | Not selected | Not selected | Applies |
View our interactive content showcase to dive into past examples of our work.
-1.jpg)
.png){kind=logo}
Most solution providers don't lack material. They lack the time and the specialist hands to turn results into content that works.
BioInsights' editors and designers are science-trained: they understand your data, know which formats this audience engages with, and get it right first time. One brief, one partner, from idea to delivery - content that goes to work instead of sitting on your website.
Your data, turned into content - without borrowing your scientists' time.
Formats chosen for what this audience engages with, not what's fashionable.
Fewer review cycles: editors who understand the science first time.
Idea to delivery with one partner, not a chain of agencies.
As a commissioning editor with extensive experience in advanced therapy journal publishing, Abi's focus is on progressing the field by facilitating and disseminating high-impact, open access content covering novel and existing cell and gene therapies.
Abi works closely with academic scientists and industry professionals to publish cutting-edge original research, expert reviews, and multimedia content with a translational and interdisciplinary focus.
Abi's key aim is to explore the latest advances in cell and gene therapy R&D, clinical development, manufacturing, and commercialization.
In addition to Abi’s editorial responsibilities, she maintains a strong network of experts across the biotech and pharma industries, staying up to date with emerging trends and breakthroughs in advanced therapies.
With a background in science communication and digital publishing, Jokubas focuses on advancing the nucleic acid therapeutics field by commissioning and shaping high-impact, open access content for Nucleic Acid Insights.
As Commissioning Editor, he leads the development of interviews, expert articles, and industry perspectives that highlight emerging advances across mRNA, DNA, oligonucleotide, and drug delivery modalities.
Jokubas is driven to translate complex scientific topics into engaging, accessible content while maintaining strong connections across the nucleic acids community.
As an editor with extensive experience in bioconjugates (i.e., ADCs, conjugate chemistry, diagnostics & imaging, bi/multi-specifics, targeted delivery, and theranostics), Lauren's focus is on advancing the field by facilitating and disseminating high-impact research on conjugation technologies and their applications.
Lauren works closely with researchers, scientists, and industry professionals to publish cutting-edge studies exploring the latest advances in conjugation chemistry, drug delivery systems, and the development and delivery of targeted therapeutics.
In addition to her editorial responsibilities, she maintains a strong network within the biopharma industry, staying up to date with emerging trends and breakthroughs in bioconjugation.
Ashling Cannon works with leading scientists and industry experts to develop high-impact, open-access content across vaccine R&D and manufacturing. She holds a BSc (Hons) in Biological Sciences and an MSc in Wild Animal Biology, with experience in biotechnology and clinical research publishing across journals and books.
Spotlights focus on key topics and emerging technologies, exploring the latest trends, challenges, and breakthroughs in the field. Each Spotlight combines independently peer-reviewed articles, opinion pieces, interviews, webinars, podcasts, short form videos, and more - delivering a comprehensive, accessible, and authoritative update for your target market.
Offer a deep dive into specialized areas of interest for BioInsights members. Each focus area provides targeted, high-value content that allows readers to explore the latest developments, challenges, and innovations
.png)